Healthcare Automation Technology Sdn Bhd’s Post

Hybrid System Spectrum Medical Ltd Spectrum Medical continues to provide new technologies specifically designed to improve performance and therefore improve patient outcomes. The Hybrid Cardiotomy-Venous System is as easy to use as a traditional hard shell system. It primes quickly and familiar Vacuum Assist approaches are easily used. The Hybrid System also provides the inherent safety of a soft bag while minimizing the need for manual air removal techniques. Whether a Team currently uses Mini-bypass, has not yet attempted Mini-bypass, uses a Soft-bag or a Hard-shell reservoir, all will appreciate the easy to use Hybrid System Technologies. The improvements provide: gross venting of venous line air, control of patient volume, options to separately handle vented and suctioned blood, utilization of common Vacuum assist techniques while avoiding the complexity of a kinetic venous assist device, and elimination of the difficulties of converting from a Mini-bypass circuit to full drainage during unpredictable clinical situations. The Hybrid System; developed to successfully address a wide variety of challenging clinical situations.

𝐓𝐡𝐞 𝐌𝐚𝐠𝐧𝐢𝐟𝐢𝐜𝐞𝐧𝐭 𝐒𝐞𝐯𝐞𝐧 in medical ultrasound!   Today over 90% of ultrasound equipment market is dominated by seven major players 1- GE HealthCare (31%) 2- Philips (19%) 3- FUJIFILM Holdings America Corporation (13%) 4- Canon Medical Systems Corporation (11%) 5- Mindray (8%) 6- Siemens Healthineers (5%) 7- Samsung Medison (5%)   The rest of the market is taken by - Esaote (3%) - 开立医疗 SonoScape (2%)

𝐓𝐡𝐞 𝐌𝐚𝐠𝐧𝐢𝐟𝐢𝐜𝐞𝐧𝐭 𝐒𝐞𝐯𝐞𝐧 in medical ultrasound!   Today over 90% of ultrasound equipment market is dominated by seven major players 1- GE HealthCare (31%) 2- Philips (19%) 3- FUJIFILM Holdings America Corporation (13%) 4- Canon Medical Systems Corporation (11%) 5- Mindray (8%) 6- Siemens Healthineers (5%) 7- Samsung Medison (5%)   The rest of the market is taken by - Esaote (3%) - 开立医疗 SonoScape (2%)

Hybrid System Spectrum Medical Ltd Spectrum Medical continues to provide new technologies specifically designed to improve performance and therefore improve patient outcomes. The Hybrid Cardiotomy-Venous System is as easy to use as a traditional hard shell system. It primes quickly and familiar Vacuum Assist approaches are easily used. The Hybrid System also provides the inherent safety of a soft bag while minimizing the need for manual air removal techniques. Whether a Team currently uses Mini-bypass, has not yet attempted Mini-bypass, uses a Soft-bag or a Hard-shell reservoir, all will appreciate the easy to use Hybrid System Technologies. The improvements provide: gross venting of venous line air, control of patient volume, options to separately handle vented and suctioned blood, utilization of common Vacuum assist techniques while avoiding the complexity of a kinetic venous assist device, and elimination of the difficulties of converting from a Mini-bypass circuit to full drainage during unpredictable clinical situations. The Hybrid System; developed to successfully address a wide variety of challenging clinical situations.

Read how Americhem Healthcare is pioneering medical grade polymers in the healthcare space!

$30+ Bn ENT Devices Market - Global and Regional Analysis and Forecast, 2024-2033: Growing Preference for Minimally Invasive Procedures, Opportunities with Demand for Cosmetic ENT Procedures - ResearchAndMarkets.com DUBLIN--(BUSINESS WIRE)--The "ENT Devices Market - A Global and Regional Analysis: Focus on Product Type, End User, and Region - Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering. The global ENT devices market was valued at $17.02 billion in 2023 and is expected to reach $30.82 billion by 2033, growing at a CAGR of 6.03% during the forecast period 2024-2033. The ENT devices market includes various medical tools used to diagnose, treat, and manage ear, via Business Wire Health: Medical Devices News

Building on the success of the OrthoCor Medical Active System™, the OrthoCor Advanced system device offers: 🔹 9-Axis Motion Sensing Technology 🔹 Compatibility with OrthoCor’s Smart Device App 🔹 Recovery Insights for Patients and Care Providers 🔹 Enhanced Visibility into Patient Usage & Pain Utilizing Pulsed Electromagnetic Field (PEMF) therapy, this device provides a drug-free and non-invasive pain relief solution. PEMF therapy works at the cellular level by facilitating ion transfer, especially calcium ions, which triggers positive biological effects to reduce pain and inflammation. Learn more about how the OrthoCor Advanced Knee device can enhance your recovery process! https://lnkd.in/g6f-kwcb #pemf #pemftherapy #painrelief #healthcare #technology #innovation #medicaldevice #medtech #medical #healthandwellness #patientwellness

📳 iRhythm Technologies International partners with BioIntelliSense, Inc on ambulatory cardiac monitoring The partnership will focus on advancing and commercialising specific patented sensor technologies in the ACM field. Under the agreement, iRhythm Technologies has been granted an exclusive licence to BioIntelliSense’s patented pulse oximetry, accelerometer, and non-invasive blood pressure technologies. These technologies will be integrated into the digital healthcare firm’s ACM products and services. Read more online: https://lnkd.in/diDDVY4P 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

Patient Monitoring and Ultrasound Devices Global Market Report 2024: Pricing, Distribution, and Promotion - Strategies for Success https://lnkd.in/e_a3QWGi #marketanalysis #marketresearch #marketresearchreports #businessintelligence

𝗗𝗮𝗶𝗹𝘆 𝗡𝗲𝘂𝗿𝗼-𝗯𝗶𝘁𝗲𝘀 🧠: 🩸Rapid Medical 𝗖𝗼𝗺𝗽𝗹𝗲𝘁𝗲𝘀 𝗜𝗻𝗶𝘁𝗶𝗮𝗹 𝗡𝗲𝘂𝗿𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗖𝗮𝘀𝗲𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗨𝗦𝗔 𝗙𝗼𝗹𝗹𝗼𝘄𝗶𝗻𝗴 𝗙𝗗𝗔 𝗖𝗹𝗲𝗮𝗿𝗮𝗻𝗰𝗲 𝗼𝗳 𝗜𝘁𝘀 𝗔𝗰𝘁𝗶𝘃𝗲 𝗔𝗰𝗰𝗲𝘀𝘀 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻 Rapid announced this year at SNIS 2024, the first procedures in the USA of their DRIVEWIRE 24 breakthrough device. DRIVEWIRE 24 redefines interventional access by providing an active 𝙙𝙚𝙛𝙡𝙚𝙘𝙩𝙖𝙗𝙡𝙚 𝙩𝙞𝙥 that controls and steers a range of catheters directly to the target vessels. 🤔𝗪𝗵𝘆 𝗱𝗼𝗲𝘀 𝘁𝗵𝗶𝘀 𝗺𝗮𝗸𝗲 𝘁𝗵𝗲𝗺 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁? Conventional access devices are reactive and rely on external forces to reach their target. DRIVEWIRE's active technology selects turns on-demand and handles the complexity of navigating the vascular highway with ease. ⭐This provides 𝙝𝙞𝙜𝙝-𝙥𝙚𝙧𝙛𝙤𝙧𝙢𝙖𝙣𝙘𝙚 𝙞𝙣𝙩𝙧𝙖𝙫𝙖𝙨𝙘𝙪𝙡𝙖𝙧 𝙨𝙩𝙚𝙚𝙧𝙞𝙣𝙜.  ⭐The device also features variable support to articulate a wide range of micro and intermediate catheters without advanced forerun or additional support devices. 🥼In the 2 cases completed by Shahram Majidi, DRIVEWIRE 24 navigated the aspiration catheter directly to the M2 arterial occlusion for first-pass excellent reperfusion. In the second case, DRIVEWIRE navigated complex turns to place 2 flow diverters in a large, multilobed aneurysm. 𝘾𝙤𝙣𝙜𝙧𝙖𝙩𝙪𝙡𝙖𝙩𝙞𝙤𝙣𝙨 to Rapid Medical!!! Ronen Eckhouse, Walid Haddad Shimon Eckhouse Giora Kornblau https://lnkd.in/e22gXu8M